GP GETEIN BIOTECH, INC. Trademark
Serial Number: 79330277 • Registration: 7141193
GP GETEIN BIOTECH, INC. is a trademark filed by
Getein Biotech, Inc.
on November 17, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Timothy T. Wang NI, WANG & MASSAND, PLLC
8140 Walnut Hill Lane
Suite 615
Dallas
TX 75231
Trademark Details
Filing Date
November 17, 2021
Registration Date
August 22, 2023
Published for Opposition
June 6, 2023
Filing History
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 11, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 22, 2023 FICS
FINAL DISPOSITION PROCESSED
Nov 22, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 22, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 22, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 22, 2023 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 26, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 7, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 7, 2023 OPNR
NOTIFICATION PROCESSED BY IB
Jun 6, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 6, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jun 6, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 17, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 17, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 17, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 4, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
May 4, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 4, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
May 4, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 4, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 27, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 27, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 27, 2023 TROA
REFUSAL PROCESSED BY IB
Nov 21, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 3, 2022 RFCS
REFUSAL PROCESSED BY MPU
Nov 3, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 10, 2022 RFCR
NON-FINAL ACTION WRITTEN
Sep 9, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 29, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 11, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 7, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 6, 2022 REPR
